Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials.

Journal of hepatology - 1 Mar 2004

Mangia Alessandra, Leandro Gioacchino, Helbling Beat, Renner Eberhard L, Tabone Marco, Sidoli Laura, Caronia Simona, Foster Graham R, Zeuzem Stephan, Berg Thomas, Di Marco Vito, Cino Nicolina, Andriulli Angelo

Abstract excerpt

BACKGROUND/AIMS: In chronic hepatitis C, clinical trials evaluating the efficacy of amantadine (AMA) and interferon (INF) compared to INF monotherapy, have produced conflicting results. We performed a meta-analysis of the individual patient's data from previous studies. METHODS: Nine hundred and seventy-two patients from six European centres were evaluated by means of individual patient meta-analysis, using mixed...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Alanine Transaminase
Share to Amantadine

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Antiviral Agents

Share to Drug Therapy, Combination

Share to Hepatitis C, Chronic

Share to Interferons

Share to Randomized Controlled Trials as Topic

Share to Viral Load

Source

Identifiers

PMID: 15123363
DOI: 10.1016/j.jhep.2003.11.002

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Combination therapy with amantadine and interferon in naïve patients with chronic hepatitis C: meta-analysis of individual patient data from six clinical trials.PMID 15123363Read ↗

A randomized trial of amantadine and interferon versus interferon alone as initial treatment for chronic hepatitis C.Semantic proximity Read ↗

Interferon alfa with or without ribavirin for chronic hepatitis C: systematic review of randomised trials.Semantic proximity Read ↗

No beneficial effects of amantadine in treatment of chronic hepatitis C patients.Semantic proximity Read ↗

A pilot study of combination therapy with initial high-dose interferon and amantadine hydrochloride for patients with chronic hepatitis C with the genotype 1b virus.Semantic proximity Read ↗

A randomized controlled trial of double versus triple therapy with amantadine for genotype 1 chronic hepatitis C in Latino patients.Semantic proximity Read ↗

Randomized, double-blind, placebo-controlled study of peginterferon alfa-2a (40KD) plus ribavirin with or without amantadine in treatment-naïve patients with chronic hepatitis C genotype 1 infection.Semantic proximity Read ↗

Combination therapy with interferon-alpha(2b), ribavirin, and amantadine in chronic hepatitis C nonresponders to interferon and ribavirin.Semantic proximity Read ↗

Amino acid variations in hepatitis C virus p7 and sensitivity to antiviral combination therapy with amantadine in chronic hepatitis C.Semantic proximity Read ↗

Effects of alpha interferon induction plus ribavirin with or without amantadine in the treatment of interferon non-responsive chronic hepatitis C: a randomised trial.Semantic proximity Read ↗

Investigation of viral escape mutations within HCV p7 during treatment with amantadine in patients with chronic hepatitis C.Semantic proximity Read ↗

Effect of interferon and ribavirin combined with amantadine in interferon and ribavirin non-responder patients with chronic hepatitis C (genotype 1).Semantic proximity Read ↗

Antiviral effects of amantadine and iminosugar derivatives against hepatitis C virus.Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.